首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Synthesis,characterization and in vitro cytotoxicity of platinum(II) complexes of selenones [Pt(selenone)2Cl2]
Authors:Ali Osman S Altoum  Ali Alhoshani  Khalid Alhosaini  Muhammad Altaf  Saeed Ahmad  Saheed A Popoola
Institution:1. Department of Chemistry, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia;2. Pharmacology and Toxicology Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;3. Center of Excellence in Nanotechnology, King Fahd University of Petroleum &4. Minerals, Dhahran, Saudi Arabia;5. Department of Chemistry, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia
Abstract:Platinum(II) complexes with various selenones (L) having the general formula PtL2Cl2] were prepared and characterized by elemental analysis and, IR and NMR (1H, 13C, and 77Se) spectroscopies. A decrease in the IR frequency of the >C=Se mode and an upfield shift in 13C NMR for the >C=Se resonance of selenones are consistent with their selenium coordination to platinum(II). The NMR data show that the complexes are stable in solution and do not undergo equilibration at 297 K. The geometrical structures of the complexes were predicted theoretically (with DFT method) using Gaussian09 program. DFT calculations predicted that the trans configurations were up to 1.7 kcal/mol more stable than the cis forms in gas phase, while in solution form the cis isomers were predicted to be more stable. The UV–vis spectra of the two complexes, 6 and 7 were also recorded at room temperature for 24 h and it was observed that the complexes were stable and did not undergo decomposition. The in vitro antitumor properties of the complexes as well as of cisplatin were evaluated on two human cancer cell lines, HeLa (cervical cancer cells) and MCF7 (breast cancer cells) using MTT assay. The results indicated that the prepared complexes exerted significant inhibition on the selected cancer cells.
Keywords:Platinum(II) complexes  cisplatin  selenones  anticancer activity
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号